Announcements Trials
Browse Landscape

Status

Completed 13Unknown 7Recruiting 6Terminated 5Active not recruiting 4Withdrawn 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 17Neoplasms 7Colorectal Neoplasms 6Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Mesothelioma 4Prostatic Neoplasms 3Ovarian Neoplasms 3Mesothelioma, Malignant 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2NSCLC 2Melanoma 2Endometrial Neoplasms 2Diabetes Mellitus 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Uterine Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Psoriasis 1Post-Lyme Disease Syndrome 1Pneumonia 1Parkinson Disease 1Pancreatic Neoplasms 1Osteosarcoma 1Obsessive-Compulsive Disorder 1Neoplasms, Squamous Cell 1

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Uterine Neoplasms × Thoracic × Clear all
NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Wake Forest University Health Sciences

Suspended
22 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡